$17.19
-0.36-2.05%
Last update: May 18, 10:47 AM
Sarepta Therapeutics Inc Earnings Estimates
SRPTNASDAQ
Sarepta Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SRPT
Sarepta Therapeutics (SRPT) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $0.54 and quarterly revenue of $362.61M.
In the most recent quarter (Q1), Sarepta Therapeutics reported EPS of $3.16, beating estimates of $0.91 by 2.47%. Revenue came in at $730.80M, exceeding the estimate of $473.58M by 0.54%.
Over the last 4 quarters, Sarepta Therapeutics has averaged an EPS surprise of 1.83% and a revenue surprise of 0.24%.
Earnings Date
Aug 5
EPS Estimate
$0.540
Quarterly Revenue Estimate
$362.61M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.18B
Sarepta Therapeutics Earnings History
Analyze the earnings history of Sarepta Therapeutics using advanced sorting and filters.
Loading calendar...
Sarepta Therapeutics (SRPT) Earnings Per Share
The chart below shows Sarepta Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Sarepta Therapeutics (SRPT) Revenue
The chart below shows Sarepta Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?
Sarepta Therapeutics (SRPT) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for Sarepta Therapeutics (NASDAQ:SRPT)?
The Actual EPS was $3.16, which beat the estimate of $0.91.
What were Sarepta Therapeutics’s (NASDAQ:SRPT) revenues?
The Actual Revenue was $730.80M, which beat the estimate of $473.58M.
